Giulia Gallerani

869 total citations
27 papers, 663 citations indexed

About

Giulia Gallerani is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Giulia Gallerani has authored 27 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 16 papers in Cancer Research and 11 papers in Molecular Biology. Recurrent topics in Giulia Gallerani's work include Cancer Cells and Metastasis (18 papers), Cancer Genomics and Diagnostics (13 papers) and Metastasis and carcinoma case studies (4 papers). Giulia Gallerani is often cited by papers focused on Cancer Cells and Metastasis (18 papers), Cancer Genomics and Diagnostics (13 papers) and Metastasis and carcinoma case studies (4 papers). Giulia Gallerani collaborates with scholars based in Italy, Poland and United Kingdom. Giulia Gallerani's co-authors include Francesco� Fabbri, Pietro Fici, Michel Rigaud, Guislaine Barrière, Wainer Zoli, Dino Amadori, Elisa Chiadini, Alessandro Passardi, Angela Ragazzini and Paola Ulivi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.

In The Last Decade

Giulia Gallerani

26 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giulia Gallerani Italy 12 421 331 241 123 119 27 663
Carolina Reduzzi Italy 14 434 1.0× 366 1.1× 200 0.8× 165 1.3× 81 0.7× 56 630
Bianca Behrens Germany 12 407 1.0× 325 1.0× 208 0.9× 84 0.7× 116 1.0× 21 598
Coyin Oh United States 5 316 0.8× 211 0.6× 208 0.9× 111 0.9× 143 1.2× 8 636
Emin Ibrahimov Canada 9 397 0.9× 239 0.7× 328 1.4× 127 1.0× 69 0.6× 12 685
Jenny E. Chu Canada 7 444 1.1× 184 0.6× 289 1.2× 81 0.7× 67 0.6× 15 619
Nadège Vimond France 11 439 1.0× 265 0.8× 185 0.8× 140 1.1× 123 1.0× 14 698
Anna Babayan Germany 10 270 0.6× 522 1.6× 437 1.8× 108 0.9× 87 0.7× 13 739
Steve Gross United States 8 541 1.3× 348 1.1× 171 0.7× 255 2.1× 138 1.2× 14 733
Marco Petronio France 4 407 1.0× 313 0.9× 166 0.7× 113 0.9× 41 0.3× 5 567
Clotilde Costa Spain 15 314 0.7× 278 0.8× 367 1.5× 64 0.5× 146 1.2× 31 677

Countries citing papers authored by Giulia Gallerani

Since Specialization
Citations

This map shows the geographic impact of Giulia Gallerani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Gallerani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Gallerani more than expected).

Fields of papers citing papers by Giulia Gallerani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Gallerani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Gallerani. The network helps show where Giulia Gallerani may publish in the future.

Co-authorship network of co-authors of Giulia Gallerani

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Gallerani. A scholar is included among the top collaborators of Giulia Gallerani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Gallerani. Giulia Gallerani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Broseghini, Elisabetta, Giulia Gallerani, G. Siepe, et al.. (2025). Vaccine-Based Immunotherapy for Oropharyngeal and Nasopharyngeal Cancers. Journal of Clinical Medicine. 14(4). 1170–1170. 3 indexed citations
2.
Rossi, Tania, Martina Valgiusti, Maurizio Puccetti, et al.. (2025). Gastroesophageal circulating tumor cell crosstalk with peripheral immune system guides CTC survival and proliferation. Cell Death and Disease. 16(1). 223–223.
3.
Gallerani, Giulia, et al.. (2023). ARID1A in cancer: Friend or foe?. Frontiers in Oncology. 13. 1136248–1136248. 30 indexed citations
4.
Gallerani, Giulia, Tania Rossi, Manuela Ferracin, & Massimiliano Bonafè. (2023). Settling the uncertainty about unconventional circulating tumor cells: Epithelial-to-mesenchymal transition, cell fusion and trogocytosis. International review of cell and molecular biology. 381. 99–111. 7 indexed citations
5.
6.
Rossi, Tania, et al.. (2022). From phenotypical investigation to RNA-sequencing for gene expression analysis: A workflow for single and pooled rare cells. Frontiers in Genetics. 13. 1012191–1012191. 2 indexed citations
7.
Vannini, Ivan, Milena Urbini, Tania Rossi, et al.. (2022). Case Report: Analysis of Plasma Extracellular Vesicles in a Triple Negative Spindle-Cell Metaplastic Breast Cancer Patient. Frontiers in Medicine. 9. 827206–827206. 1 indexed citations
8.
Rossi, Tania, Giulia Gallerani, Giovanni Martinelli, Roberta Maltoni, & Francesco� Fabbri. (2021). Circulating Tumor Cells as a Tool to Untangle the Breast Cancer Heterogeneity Issue. Biomedicines. 9(9). 1242–1242. 12 indexed citations
9.
Rossi, Tania, Emanuela Scarpi, Giulia Gallerani, et al.. (2021). Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast Cancer. Frontiers in Molecular Biosciences. 8. 732900–732900. 11 indexed citations
10.
Rossi, Tania, Michela Palleschi, Michela Tebaldi, et al.. (2021). Case Report: Analysis of Circulating Tumor Cells in a Triple Negative Spindle-Cell Metaplastic Breast Cancer Patient. Frontiers in Medicine. 8. 689895–689895. 4 indexed citations
11.
Maltoni, Roberta, Michela Palleschi, Giulia Gallerani, et al.. (2020). Impressive long-term response with chemo-endocrine therapy in a premenopausal patient with metastatic breast cancer. Medicine. 99(24). e20396–e20396. 1 indexed citations
12.
Gallerani, Giulia, et al.. (2019). Crowdfunding for cancer research: the TRACe campaign as an example. The Lancet Oncology. 20(5). 622–624. 4 indexed citations
13.
Carloni, Silvia, Giulia Gallerani, Anna Tesei, et al.. (2017). DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy. OncoTargets and Therapy. Volume 10. 4657–4664. 3 indexed citations
14.
Gallerani, Giulia, Pietro Fici, & Francesco� Fabbri. (2017). Circulating Tumor Cells: Back to the Future. Frontiers in Oncology. 6. 275–275. 8 indexed citations
15.
16.
Gallerani, Giulia, Claudia Cocchi, Martine Bocchini, Filippo Piccinini, & Francesco� Fabbri. (2017). Characterization of Tumor Cells Using a Medical Wire for Capturing Circulating Tumor Cells: A 3D Approach Based on Immunofluorescence and DNA FISH. Journal of Visualized Experiments. 6 indexed citations
17.
Maltoni, Roberta, Giulia Gallerani, Pietro Fici, Andrea Rocca, & Francesco� Fabbri. (2016). CTCs in early breast cancer: A path worth taking. Cancer Letters. 376(2). 205–210. 25 indexed citations
18.
Gallerani, Giulia, et al.. (2015). The GILUPI CellCollector as an in vivo tool for circulating tumor cell enumeration and molecular characterization in lung cancer patients.. Journal of Clinical Oncology. 33(15_suppl). e22035–e22035. 4 indexed citations
19.
Barrière, Guislaine, Pietro Fici, Giulia Gallerani, Francesco� Fabbri, & Michel Rigaud. (2015). Epithelial Mesenchymal Transition: a double‐edged sword. SHILAP Revista de lepidopterología. 4(1). 14–14. 110 indexed citations
20.
Fabbri, Francesco�, Silvia Carloni, Wainer Zoli, et al.. (2013). Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs. Cancer Letters. 335(1). 225–231. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carolina Reduzzi Breakdown of academic impact, for papers by Bianca Behrens Breakdown of academic impact, for papers by Coyin Oh Breakdown of academic impact, for papers by Emin Ibrahimov Breakdown of academic impact, for papers by Jenny E. Chu Breakdown of academic impact, for papers by Nadège Vimond Breakdown of academic impact, for papers by Anna Babayan Breakdown of academic impact, for papers by Steve Gross Breakdown of academic impact, for papers by Marco Petronio Breakdown of academic impact, for papers by Clotilde Costa
Rankless by CCL
2026